PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy

PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy

Diabetic cardiomyopathy (DCM) is a specific type of myocardial disease that often develops in patients suffering from diabetes, which has become the foremost cause of death among them. It is an insidious multifactorial disease caused by complex and partially unknown mechanisms that include metabolic...

Full description

Bibliographic Details
Main Authors: Adel Rostami, Xavier Palomer, Javier Pizarro-Delgado, Emma Barroso, Brenda Valenzuela-Alcaraz, Fátima Crispi, J. Francisco Nistal, María A. Hurlé, Raquel García, Walter Wahli, Manuel Vázquez-Carrera
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Pharmacological Research
Subjects:
Activator protein-1 (AP-1)
Diabetic cardiomyopathy
Fibrosis
Inflammation
Mitogen-activated protein kinases (MAPK)
Nuclear factor κB (NF-κB)
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661824004602

Internet

http://www.sciencedirect.com/science/article/pii/S1043661824004602

Similar Items